Decentralized Vaccine Making: A New Path to Fair Access

The world has learned that when only a few places can make vaccines, shortages and delays become inevitable. The COVID‑19 crisis showed that a single, concentrated production model can leave many countries behind when a new disease strikes. In response, a group of 32 research and public health